Literature DB >> 6821094

Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates.

A Sivonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6821094     DOI: 10.1016/s0163-4453(81)90934-8

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  6 in total

Review 1.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

2.  An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting.

Authors:  B E Kristiansen; B Sørensen; B Bjorvatn; E S Falk; E Fosse; K Bryn; L O Frøholm; P Gaustad; K Bøvre
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Meningococcal phenotypic and genotypic characteristics and human antibody levels.

Authors:  B E Kristiansen; K W Lind; K Mevold; B Sørensen; L O Frøholm; K Bryn; T Tjade; K Bøvre
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

Review 5.  The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?

Authors:  Martin C J Maiden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

6.  Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.

Authors:  Mogens Kilian; Steffen Husby; Jesper Andersen; Zina Moldoveanu; Uffe B Skov Sørensen; Jesper Reinholdt; Hervé Tettelin
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.